CH365379A - Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function - Google Patents

Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function

Info

Publication number
CH365379A
CH365379A CH3228356A CH3228356A CH365379A CH 365379 A CH365379 A CH 365379A CH 3228356 A CH3228356 A CH 3228356A CH 3228356 A CH3228356 A CH 3228356A CH 365379 A CH365379 A CH 365379A
Authority
CH
Switzerland
Prior art keywords
aniline
phenyl
sulfur
phenothiazines
phenothiazine
Prior art date
Application number
CH3228356A
Other languages
German (de)
Inventor
Jany Dr Renz
Pierre Dr Bourquin Jean
Guido Dr Gamboni
Schwarb Gustav
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH3228356A priority Critical patent/CH365379A/en
Priority to CH5646256A priority patent/CH364794A/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH360059D priority patent/CH360059A/en
Priority claimed from CH4301757A external-priority patent/CH364782A/en
Priority to ES0234296A priority patent/ES234296A1/en
Priority to DE1957S0052942 priority patent/DE1128856B/en
Priority to GB1105057A priority patent/GB863547A/en
Priority to GB1738060A priority patent/GB863550A/en
Priority to US653058A priority patent/US3239514A/en
Priority to BE556725A priority patent/BE556725A/xx
Priority to NL216435A priority patent/NL105267C/xx
Priority to FR1174268D priority patent/FR1174268A/en
Priority to NL216436A priority patent/NL105268C/xx
Priority to BE565470A priority patent/BE565470A/xx
Priority to FR1203557D priority patent/FR1203557A/en
Priority to DE1958S0057244 priority patent/DE1090667B/en
Priority to CH5676458A priority patent/CH374675A/en
Priority to NL225621A priority patent/NL108580C/xx
Priority to GB748158A priority patent/GB858140A/en
Publication of CH365379A publication Critical patent/CH365379A/en
Priority to CY27564A priority patent/CY275A/en
Priority to US420821A priority patent/US3336197A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0025Crosslinking or vulcanising agents; including accelerators
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M135/00Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing sulfur, selenium or tellurium
    • C10M135/32Heterocyclic sulfur, selenium or tellurium compounds
    • C10M135/36Heterocyclic sulfur, selenium or tellurium compounds the ring containing sulfur and carbon with nitrogen or oxygen
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01GCAPACITORS; CAPACITORS, RECTIFIERS, DETECTORS, SWITCHING DEVICES OR LIGHT-SENSITIVE DEVICES, OF THE ELECTROLYTIC TYPE
    • H01G9/00Electrolytic capacitors, rectifiers, detectors, switching devices, light-sensitive or temperature-sensitive devices; Processes of their manufacture
    • H01G9/004Details
    • H01G9/08Housing; Encapsulation
    • H01G9/10Sealing, e.g. of lead-in wires
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • C10M2219/104Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
    • C10M2219/108Phenothiazine

Description

  

  Verfahren zur Herstellung von neuen, in 3-Stellung mit einer einwertigen Schwefelfunktion  substituierten Phenothiazinen    Es wurde gefunden, dass man zu neuen, in     3-Stel-          lung    mit einer einwertigen Schwefelfunktion substi  tuierten Phenothiazinen der Formel  
EMI0001.0002     
    R = H, Alkyl mit 1-4 C-Atomen, Alkenyl mit  2-4 C-Atomen, Aryl, Aralkyl oder Acyl  gelangen kann, indem man Diphenylamin, dessen  einer Phenylkern in m-Stellung den Substituenten  -S-R trägt, mit elementarem Schwefel oder mit  Schwefeldihalogeniden behandelt. Gegebenenfalls  werden die dabei entstandenen Stellungsisomeren  voneinander getrennt.  



  Reaktions       iphenyl-          Es    war an sich schon bekannt, dass  produkt       ubsti-          henylkern    einen  aminderivate,die  tuenten in m-Stellung tragen, beim Thiazinringschluss  mit Schwefelungsmitteln 2 isomere Phenothiazine  liefern, die sich voneinander durch die Stellung des  ohne  Substituenten an einem Benzolkern unterscheiden.  



  59     [19S2])     Charpentier und Mitarbeiter (C. r.  



  konnten beweisen, dass Phenothiazine mit einfacher       ub-          ethyl,    die den  Substitution durch Chlor oder  3 tragen, den höheren     Schmelz-          stituenten     punkt besitzen, als die in Stellung 1 substituierten  Isomeren.  



  Durch die Einführung einer einwertigen Schwefel  funktion in das Phenothiazingerüst unterscheiden sich  die nach dem vorliegenden Verfahren hergestellten  grundsätzlich von den  neuen     Phenothiazin-          bisher    bekannten Phenothiazinen.    Das erfindungsgemässe     Verfahren        kann    beispiels  weise so ausgeführt werden, dass man ein     N-(m-Alkyl-          mercapto-phenyl)-anilin    mit elementarem Schwefel  in Gegenwart von kristallisiertem Jod     als    Katalysator  auf 100-200  erhitzt. Nach Beendigung der Schwe  felwasserstoffentwicklung wird das Reaktionsprodukt  nach an sich bekannten Methoden     gereinigt,    z. B.

    durch Umkristallisieren, wobei eventuell nebeneinan  der entstandene Stellungsisomere voneinander ge  trennt werden können.  



  Die Erfindung umfasst auch folgende Ausfüh  rungsform des Verfahrens: Die Lösung eines     N-(m-          Alkylmercapto-phenyl)-anilins    in einem inerten, mit  Wasser nicht mischbaren organischen Lösungsmittel,  wie Benzol, Toluol, Xylol oder Chlorbenzol wird mit  einem Schwefeldihalogenid, wie Schwefeldichlorid,  versetzt. Nach Abdampfen des Lösungsmittels unter  Normaldruck oder im Vakuum wird das  durch Umkristallisieren gereinigt, wobei ge  gebenenfalls die nebeneinander entstandenen     Stel-          lungsisomeren    durch fraktionierte Kristallisation ge  trennt werden. Die Reaktionspartner     können    auch  Lösungsmittel miteinander zur Reaktion ge  bracht werden.  



  Die Rohprodukte können auch durch Destillation  im Hochvakuum     gereinigt    werden. Ferner ist die Rei  nigung durch Chromatographie, z. B. an Aluminium  oxyd, anwendbar, wobei in gewissen Fällen insbeson  dere die Trennung der Stellungsisomeren erleichtert  werden     kann.     



  Die nach dem     vorliegenden        Verfahren    hergestell  ten, bisher unbekannten Mercapto-phenothiazine sind  bei Zimmertemperatur feste oder flüssige     Substanzen.     Sie sollen als Vulkanisationsbeschleuniger oder als       Antioxydantien    für Schmiermittel, oder als Anthel-      minthica verwendet werden, dienen aber auch als  Zwischenprodukte zur Herstellung von Therapeutica,  indem sie z. B. nach dem im Schweizer Patent  Nr. 360059 beschriebenen Verfahren in Substanzen  mit wertvollen therapeutischen Eigenschaften über  geführt werden können. Diese vermögen z.

   B. die  Wirkung von narkotisch, hypnotisch oder analgetisch  wirkenden Pharmaka zu verstärken oder können als  Neuroplegika, Spasmolytika oder auch als     Anti-          histaminika    verwendet werden.  



  <I>Beispiel 1</I>  3-Methylmercapto-phenothiazin  Man erhitzt 9,87 g N - (m -     Methylmercapto-          phenyl)-anilin    mit 2,93 g Schwefel und 0,15 g pulve  risiertem Jod während 15 Min. in einem Bad von  etwa 160 . Nach Beendigung der Schwefelwasser  stoff-Entwicklung wird das Reaktionsgemisch unter  Zusatz von Tierkohle zuerst aus 40 cm  Chlorbenzol,  dann aus 25-30 cm  Benzol in der Siedehitze um-'  kristallisiert. Das zitronengelbe     3-Methylmercapto-          phenothiazin    hat den Smp. 138-140 .  



  Der     Ausgangsstoff    kann erhalten werden, indem  man m - Methylmercapto - anilin (Sdp. 163-165 ;  16 mm Hg) mit dem Kaliumsalz der     o-Chlor-benzoe-          säure    kondensiert und die entstandene     N-(m-Methyl-          mercapto-phenyl)-anthranilsäure    (Smp. 139-141 )  durch Erhitzen und anschliessende Destillation zum  N-(m-Methylmercapto-phenyl)-anilin (Smp. 59-61 )  dekarboxyliert.  



  <I>Beispiel 2</I>  3-Äthylmercapto-phenothiazin  Man erhitzt 5,39g     N-(m-Äthylmercapto-phenyl)-          anilin    mit 1,51 g Schwefel und 0,1 g pulverisiertem  Jod während 12 Minuten in einem Bad von etwa  160 . Nach Beendigung der Schwefelwasserstoff  entwicklung wird das Reaktionsgemisch unter Zu  satz von Tierkohle zuerst aus 15 cm  Chlorbenzol  umkristallisiert. Die Kristalle löst man in 12 cm   siedendem Benzol und versetzt die warme Lösung  mit 12 cm  Petroläther, wonach     3-Äthylmercapto-          phenothiazin    als schwach gelb gefärbte kristallisierte  Substanz von Smp. 95-97  erhalten wird.  



  Der Ausgangsstoff kann erhalten werden, indem  man m - Äthylmercapto - anilin (Sdp. 147-152 ;  10 mm Hg) mit dem Kaliumsalz der     o-Chlor-benzoe-          säure    kondensiert und die entstandene     N-(m-Äthyl-          mercapto-phenyl)-anthranilsäure    (Smp. 114-116 )  durch Erhitzen und anschliessende Destillation zum  N - (m - Äthylmercapto - phenyl)-anilin (Sdp. 140 /  0,007 mm Hg) dekarboxyliert.  



  <I>Beispiel 3</I>  3-Isopropylmercapto-phenothiazin  Man erhitzt 17,0 g     N-(m-Isopropyhnercapto-          phenyl)-anilin    mit 4,47 g Schwefel und 0,2 g pulve  risiertem Jod während 1/2 Stunde in einem Bad von  160 . Nach Beendigung der     Schwefelwasserstoff-          Entwicklung    wird die     Reaktionsmasse    in 25 cm:,    Benzol gelöst, filtriert, und das warme Filtrat mit  40 cm  Petroläther versetzt, wonach sich     3-Isopropyl-          mercapto-phenothiazin    kristallin abscheidet.

   Nach  dem Umkristallisieren aus 25 cm  Benzol und 40 cm  Petroläther erhält man das analysenreine     3-Isopropyl-          mercapto-phenothiazin    vom Smp. l18-120  als  zitronengelbe Kristalle.  



  Der Ausgangsstoff kann erhalten werden, indem  man m-Isopropylmercapto-nitrobenzol (Sdp. 148 bis  150 /11 mm Hg) mit Stannochlorid und Salzsäure  zu m - Isopropylmercapto - anilin (Sdp. 142-144 /  10 mm Hg) reduziert, dieses mit dem Kaliumsalz der  o-Chlorbenzoesäure kondensiert und die entstandene  N-(m-Isopropyhnercapto-phenyl)-anthranilsäure (Smp.  114-116 ) durch Erhitzen und anschliessende Destil  lation zum N-(m-Isopropylmercapto-phenyl)-anilin  (Sdp. 143 J0,005 mm Hg) dekarboxyliert.  



  <I>Beispiel 4</I>  3-n-Propylmercapto-phenothiazin  Man erhitzt 25,8 g     N-(m-n-Propylmercapto-          phenyl)-anilin    mit 6,75 g Schwefel und 0,35 g pulve  risiertem Jod während 2 Stunden in einem Bad von  160 . Nach Beendigung der     Schwefelwasserstoff-          Entwicklung    wird die Reaktionsmasse im Vakuum  destilliert. Nach Abtrennen eines unter 0,03 mm Hg  bis 202  übergehenden Vorlaufes destilliert die  Hauptfraktion bei 202-210 j0,03 mm Hg über.  Das Destillat wird in 100 cm  Benzol gelöst, filtriert,  und das warme Filtrat mit 100 cm  Petroläther ver  setzt. Nach nochmaligem Umkristallisieren aus  100 cm  Benzol und 100 cm  Petroläther erhält man  das analysenreine 3-n-Propylmercapto-phenothiazin  vom Smp. 107-109  als blassgelbe Blättchen.

    



  Der Ausgangsstoff kann erhalten werden, indem  man m-n-Propylmercapto-nitrobenzol (Sdp. 163 bis  165 /11 mm Hg) mit Stannochlorid und Salzsäure zu  m-n-Propylmercapto-anilin (Sdp. 154-157 /11 mm  Hg) reduziert, dieses mit dem Kaliumsalz der     o-Chlor-          benzoesäure    kondensiert und die entstandene     N-(m-n-          Propylmercapto-phenyl)-anthranilsäure    (Smp. 99 bis  101 ) durch     Erhitzen    und anschliessende Destillation  zum N-(m-n-Propylmercapto-phenyl)-anilin (Sdp. 170  bis 172 /0,01 mm Hg) dekarboxyliert.  



  <I>Beispiel 5</I>  3-n-Butylmercapto-phenothiazin  Man erhitzt 8,0 g     N-(m-n-Butylmercapto-phenyl)-          anilin    mit 2,0 g Schwefel und 0,1 g pulv. Jod wäh  rend einer Viertelstunde in einem Bad von 160 .  Nach Beendigung der Schwefelwasserstoff-Entwick  lung wird die Reaktionsmasse in 12 cm:, Benzol ge  löst, filtriert, und das warme Filtrat mit 12 cm   Petroläther versetzt, wonach sich     3-n-Butylmercapto-          phenothiazin    kristallin abscheidet.

   Nach dem Um  kristallisieren aus 12 cm"- Benzol und 15     cm3        Petrol-          äther    erhält man das analysenreine     3-n-Butylmercapto-          phenothiazin    vom     Smp.    104-l06  als gelbe Kri  stalle.      Der Ausgangsstoff kann erhalten werden, indem  man m-n-Butylmercapto-anilin (Sdp. 172-176 1  13 mm Hg) mit dem Kaliumsalz der     o-Chlorbenzoe-          säure    kondensiert und die entstandene     N-(m-n-Butyl-          mercapto    - phenyl) - anthranilsäure (Smp. 77-79 )  durch Erhitzen und anschliessende Destillation (Sdp.

    1.68-1.72 j0,01 mm Hg) zum     N-(m-n-Butylmercapto-          phenyl)-anilin    dekarboxyliert (Smp. 30-32  aus  Petroläther).  



  <I>Beispiel 6</I>  3-Isobutylmercapto-phenothiazin  Man erhitzt 20,0 g     N-(m-i-Butylmercapto-phenyl)-          anilin    mit 4,97 g Schwefel und 0,25 g pulv. Jod  während einer halben Stunde in einem Bad von 160 .  Nach Beendigung der Schwefelwasserstoff-Entwick  lung wird die Reaktionsmasse im Hochvakuum  destilliert. Nach Abtrennen eines bis 209  bei  0,06 mm Hg übergehenden Vorlaufes destilliert die  Hauptfraktion, das 3-i-Butylmercapto-phenothiazin,  bei 209-21l  bei 0,06 mm Hg, über. Das Destillat  wird aus 65 cm  95% igem Äthanol umkristallisiert.  Das analysenreine blassgelbe     3-i-Butylmercapto-          phenothiazin    hat den Smp. 94-96 .  



  Der Ausgangsstoff kann erhalten werden, indem  man m-i-Butylmercapto-anilin (Sdp. 168 114 mm Hg)  mit dem Kaliumsalz der o-Chlorbenzoesäure konden  siert und die entstandene     N-(m-i-Butylmercapto-          phenyl)-anthranilsäure    (Smp. 107-109 ) durch Er  hitzen auf 250  dekarboxyliert. Anschliessend wird  das entstandene N-(m-i-Butylmercapto-phenyl)-anilin  im Hochvakuum destilliert. Sdp. 148  bei 0,008 mm  Hg.  



  <I>Beispiel 7</I>  3-sek.-n-Butylmercapto-phenothiazin  Man erhitzt 40,0 g     N-(m-sek.-n-Butylmercapto-          phenyl)-anilin    mit 9,94 g Schwefel und 0,50 g pulv.  Jod während einer Stunde in einem Bad von 160 .  Nach Beendigung der Schwefelwasserstoff-Entwick  lung wird die Reaktionsmasse im Hochvakuum destil  liert. Nach Abtrennen eines bis 205  bei 0,08 mm Hg  übergehenden Vorlaufes, destilliert die Hauptfraktion,  das 3-sek.-n-Butylmercapto-phenothiazin bei 205 bis  210  bei 0,08 mm Hg über. Das Destillat wird aus  75 cm  95% igem Äthanol umkristallisiert. Das ana  lysenreine, blassgelbe     3-sek.-n-Butylmercapto-pheno-          thiazin    hat den Smp. 88-90 .  



  Der Ausgangsstoff kann erhalten werden, indem  man m-sek.-n-Butylmercapto-anilin (Sdp. 160 114 mm  Hg) mit dem Kaliumsalz der o-Chlorbenzoesäure  kondensiert und die entstandene     N-(m-sek.-n-Butyl-          mercapto    - phenyl) - anthranilsäure (Smp. 68-70 )  durch Erhitzen auf 250  dekarboxyliert. Anschliessend  wird das entstandene     N-(m-sek.-n-Butylmercapto-          phenyl)-anilin    im Hochvakuum destilliert. Sdp. 160   bei 0,008 mm Hg.  



  <I>Beispiel 8</I>  3-Benzylmercapto-phenothiazin  Man erhitzt 46,0g     N-(m-Benzyhnercapto-phenyl)-          anilin    mit 10,1 g Schwefel und 0,5 g pulverisiertem    Jod während einer halben Stunde in einem Bad von  160 . Nach Beendigung der Schwefelwasserstoff-Ent  wicklung wird die Reaktionsmasse aus der vierfachen  Menge siedendem Benzol umkristallisiert. Das analy  senreine blassgelbe 3-Benzylmercapto-phenothiazin  hat den Smp. 155-157 .  



  Der     Ausgangsstoff    kann erhalten werden, indem  man m-Benzylmercapto-anilin vom Sdp. 163  bei  0,06 mm Hg mit dem Kaliumsalz der     o-Chlor-          benzoesäure    kondensiert und die entstandene     N-(m-          Benzylmercapto    - phenyl) - anthranilsäure (Smp. 137  bis 139 ) durch Erhitzen auf 250  dekarboxyliert.  Anschliessend wird das entstandene     N-(m-Benzyl-          mercapto-phenyl)-anilin    im Hochvakuum destilliert.  Sdp. 2l4  bei 0,2 mm Hg, Smp. 61-63 .  



  <I>Beispiel 9</I>  3-Phenylmercapto-phenothiazin  _ Man erhitzt 10,0g     N-(m-Phenylmercapto-phenyl)-          anilin,    2,31 g Schwefel und 0,1 g Jodpulver während  20 Minuten in einem Bad von etwa 160 . Sobald die  Schwefelwasserstoff-Entwicklung praktisch beendet  ist, wird das     Reaktionsgemisch    unter Zusatz von  Tierkohle zuerst aus 60 cm , dann ein zweites Mal  aus 50 cm  siedendem Benzol umkristallisiert. Das  blassgelbe analysenreine 3 - Phenyhnercapto -     pheno-          thiazin    hat den konstanten Smp. 163-165 .  



  Das während dieser Reaktion sich möglicherweise  bildende weitere Isomere befindet sich in der Mutter  lauge.  



  Der     Ausgangsstoff    kann erhalten werden, indem  man m-Jod-anilin (Sdp. 145-146 115 mm Hg) mit  dem Kaliumsalz der o-Chlorbenzoesäure kondensiert  und die entstandene N-(m-Jod-phenyl)-anthranilsäure  (Smp. 168-170 ) durch Erhitzen und anschliessende  Destillation zum N-(m-Jod-phenyl)-anilin (Sdp. 140  bis 143 10,05 mm Hg) dekarboxyliert. Das erhaltene  N-(m-Jod-phenyl)-anilin wird durch Kondensation  mit Natrium-thiophenolat in Anwesenheit von  Kupferpulver zum N - (m - Phenylmercapto -     phenyl)-          anilin    (Sdp. 176 10,005 mm Hg) umgesetzt.



  Process for the preparation of new phenothiazines substituted in the 3-position with a monovalent sulfur function It has been found that new phenothiazines of the formula ## STR3 ## which are substituted in the 3-position with a monovalent sulfur function can be obtained
EMI0001.0002
    R = H, alkyl with 1-4 carbon atoms, alkenyl with 2-4 carbon atoms, aryl, aralkyl or acyl can be obtained by diphenylamine, one of which has a phenyl nucleus in the m-position bearing the substituent -SR, with elemental sulfur or treated with sulfur dihalides. If necessary, the positional isomers formed are separated from one another.



  Reaction iphenyl- It was already known that the product ubsthenyl nucleus has an amine derivative which has tuentene in the m-position, when thiazine ring closure with sulphurizing agents gives 2 isomeric phenothiazines which differ from one another in the position of the without substituent on a benzene nucleus.



  59 [19S2]) Charpentier and co-workers (C. r.



  were able to prove that phenothiazines with simple ubethyl, which are substituted by chlorine or 3, have the higher melting point than the isomers substituted in the 1 position.



  The introduction of a monovalent sulfur function into the phenothiazine structure means that the phenothiazines produced by the present process differ fundamentally from the new phenothiazines known to date. The process according to the invention can, for example, be carried out by heating an N- (m-alkyl-mercapto-phenyl) -aniline with elemental sulfur in the presence of crystallized iodine as a catalyst to 100-200. After the evolution of sulfur has ended, the reaction product is purified by methods known per se, e.g. B.

    by recrystallization, in which case the positional isomers formed next to one another can be separated from one another.



  The invention also includes the following embodiment of the process: The solution of an N- (m-alkylmercapto-phenyl) -aniline in an inert, water-immiscible organic solvent, such as benzene, toluene, xylene or chlorobenzene, is mixed with a sulfur dihalide, such as sulfur dichloride , offset. After the solvent has been evaporated off under normal pressure or in vacuo, it is purified by recrystallization, the positional isomers formed next to one another being separated by fractional crystallization if necessary. The reactants can also be made to react solvents with one another.



  The crude products can also be purified by distillation in a high vacuum. Furthermore, the purification is by chromatography, e.g. B. aluminum oxide, applicable, in certain cases in particular the separation of the positional isomers can be facilitated.



  The previously unknown mercapto-phenothiazines produced by the present process are solid or liquid substances at room temperature. They are intended to be used as vulcanization accelerators or as antioxidants for lubricants, or as anthelmintics, but also serve as intermediates for the production of therapeutics, by z. B. according to the method described in Swiss Patent No. 360059 in substances with valuable therapeutic properties over. These are able to z.

   B. to increase the effect of narcotic, hypnotic or analgesic drugs or can be used as neuroplegics, spasmolytics or as antihistamines.



  <I> Example 1 </I> 3-Methylmercapto-phenothiazine 9.87 g of N - (m - methylmercapto-phenyl) -aniline are heated with 2.93 g of sulfur and 0.15 g of powdered iodine for 15 minutes in a bath of about 160. After the evolution of hydrogen sulphide has ended, the reaction mixture is recrystallized with the addition of animal charcoal first from 40 cm of chlorobenzene, then from 25-30 cm of benzene at the boiling point. The lemon-yellow 3-methylmercaptophenothiazine has the melting point 138-140.



  The starting material can be obtained by condensing m - methyl mercapto aniline (bp 163-165; 16 mm Hg) with the potassium salt of o-chloro-benzoic acid and the resulting N- (m-methyl mercapto-phenyl) Anthranilic acid (melting point 139-141) is decarboxylated by heating and subsequent distillation to give N- (m-methylmercapto-phenyl) aniline (melting point 59-61).



  <I> Example 2 </I> 3-Ethylmercapto-phenothiazine 5.39 g of N- (m-ethylmercapto-phenyl) aniline are heated with 1.51 g of sulfur and 0.1 g of powdered iodine for 12 minutes in a bath of about 160. After the evolution of hydrogen sulfide has ended, the reaction mixture is first recrystallized from 15 cm of chlorobenzene with the addition of animal charcoal. The crystals are dissolved in 12 cm of boiling benzene and 12 cm of petroleum ether are added to the warm solution, after which 3-ethylmercaptophenothiazine is obtained as a pale yellow crystallized substance of melting point 95-97.



  The starting material can be obtained by condensing m-ethyl mercapto-aniline (bp 147-152; 10 mm Hg) with the potassium salt of o-chloro-benzoic acid and the resulting N- (m-ethyl mercapto-phenyl) Anthranilic acid (melting point 114-116) is decarboxylated by heating and subsequent distillation to give N - (m - ethyl mercapto - phenyl) aniline (b.p. 140 / 0.007 mm Hg).



  <I> Example 3 </I> 3-Isopropylmercapto-phenothiazine 17.0 g of N- (m-isopropylmercapto-phenyl) -aniline are heated with 4.47 g of sulfur and 0.2 g of powdered iodine for 1/2 hour in a bath of 160. After the evolution of hydrogen sulfide has ended, the reaction mass is dissolved in 25 cm: benzene, filtered, and 40 cm petroleum ether is added to the warm filtrate, after which 3-isopropyl-mercapto-phenothiazine precipitates in crystalline form.

   After recrystallization from 25 cm benzene and 40 cm petroleum ether, analytically pure 3-isopropyl mercapto-phenothiazine with a melting point of 118-120 is obtained as lemon-yellow crystals.



  The starting material can be obtained by reducing m-isopropylmercapto-nitrobenzene (b.p. 148 to 150/11 mm Hg) with stannous chloride and hydrochloric acid to m-isopropyl mercapto-aniline (b.p. 142-144 / 10 mm Hg), this with the The potassium salt of o-chlorobenzoic acid condenses and the resulting N- (m-isopropylmercapto-phenyl) -anthranilic acid (melting point 114-116) by heating and subsequent distillation to form N- (m-isopropylmercapto-phenyl) -aniline (bp. 143 J0 , 005 mm Hg) decarboxylated.



  <I> Example 4 </I> 3-n-Propylmercapto-phenothiazine 25.8 g of N- (mn-propylmercapto-phenyl) -aniline are heated with 6.75 g of sulfur and 0.35 g of powdered iodine for 2 hours in a bath of 160. When the evolution of hydrogen sulfide has ended, the reaction mass is distilled in vacuo. After separating off a forerun which passes below 0.03 mm Hg to 202, the main fraction distills over at 202-210 j0.03 mm Hg. The distillate is dissolved in 100 cm of benzene, filtered, and the warm filtrate is ver with 100 cm of petroleum ether. After repeated recrystallization from 100 cm benzene and 100 cm petroleum ether, the analytically pure 3-n-propylmercapto-phenothiazine with a melting point of 107-109 is obtained as pale yellow leaflets.

    



  The starting material can be obtained by reducing mn-propylmercapto-nitrobenzene (b.p. 163 to 165/11 mm Hg) with stannous chloride and hydrochloric acid to mn-propylmercapto-aniline (b.p. 154-157 / 11 mm Hg), this with the The potassium salt of o-chlorobenzoic acid condenses and the resulting N- (mn-propylmercapto-phenyl) -anthranilic acid (m.p. 99 to 101) by heating and subsequent distillation to form N- (mn-propylmercapto-phenyl) -aniline (b.p. 170 up to 172 / 0.01 mm Hg) decarboxylated.



  <I> Example 5 </I> 3-n-Butylmercapto-phenothiazine 8.0 g of N- (mn-butylmercapto-phenyl) -aniline are heated with 2.0 g of sulfur and 0.1 g of powdered iodine for one A quarter of an hour in a bath of 160. After the evolution of hydrogen sulfide has ended, the reaction mass is dissolved in 12 cm :, benzene, filtered, and 12 cm of petroleum ether are added to the warm filtrate, after which 3-n-butylmercaptophenothiazine precipitates in crystalline form.

   After recrystallizing from 12 cm "benzene and 15 cm3 petroleum ether, the analytically pure 3-n-butyl mercaptophenothiazine with a melting point of 104-106 is obtained as yellow crystals. The starting material can be obtained by adding mn-butyl mercapto aniline (bp. 172-176 1,13 mm Hg) condensed with the potassium salt of o-chlorobenzoic acid and the resulting N- (mn-butyl mercapto - phenyl) anthranilic acid (mp 77-79) by heating and subsequent distillation (Sdp.

    1.68-1.72 j0.01 mm Hg) decarboxylated to N- (m-n-butylmercaptophenyl) aniline (m.p. 30-32 from petroleum ether).



  <I> Example 6 </I> 3-Isobutylmercapto-phenothiazine 20.0 g of N- (mi-butylmercapto-phenyl) - aniline with 4.97 g of sulfur and 0.25 g of powdered iodine are heated in for half an hour a bath of 160. After the development of hydrogen sulfide has ended, the reaction mass is distilled in a high vacuum. After separating off a forerun that fades to 209 at 0.06 mm Hg, the main fraction, the 3-i-butylmercapto-phenothiazine, distills over at 209-21 l at 0.06 mm Hg. The distillate is recrystallized from 65 cm of 95% ethanol. The analytically pure pale yellow 3-i-butyl mercaptophenothiazine has the melting point 94-96.



  The starting material can be obtained by condensing mi-butylmercapto-aniline (bp. 168 114 mm Hg) with the potassium salt of o-chlorobenzoic acid and the resulting N- (mi-butylmercaptophenyl) -anthranilic acid (melting point 107-109 ) decarboxylated by heating to 250. The N- (m-i-butylmercapto-phenyl) -aniline formed is then distilled in a high vacuum. Bp 148 at 0.008 mm Hg.



  <I> Example 7 </I> 3-sec-n-butylmercapto-phenothiazine 40.0 g of N- (m-sec-n-butylmercaptophenyl) aniline are heated with 9.94 g of sulfur and 0, 50 g of powdered iodine for one hour in a bath of 160. After the development of hydrogen sulfide has ended, the reaction mass is distilled in a high vacuum. After separating a forerun that fades to 205 at 0.08 mm Hg, the main fraction, the 3-sec-n-butylmercapto-phenothiazine, distills over at 205 to 210 at 0.08 mm Hg. The distillate is recrystallized from 75 cm of 95% ethanol. The analytically pure, pale yellow 3-sec-n-butylmercapto-phenothiazine has the melting point 88-90.



  The starting material can be obtained by condensing m-sec-n-butyl mercapto-aniline (bp. 160 114 mm Hg) with the potassium salt of o-chlorobenzoic acid and the resulting N- (m-sec-n-butyl mercapto - phenyl) - anthranilic acid (m.p. 68-70) decarboxylated by heating to 250. The N- (m-sec-n-butylmercaptophenyl) aniline formed is then distilled in a high vacuum. Bp 160 at 0.008 mm Hg.



  <I> Example 8 </I> 3-Benzylmercapto-phenothiazine 46.0 g of N- (m-benzyl mercapto-phenyl) aniline are heated with 10.1 g of sulfur and 0.5 g of powdered iodine for half an hour in a bath from 160. After the evolution of hydrogen sulfide has ended, the reaction mass is recrystallized from four times the amount of boiling benzene. The analytically pure pale yellow 3-benzylmercapto-phenothiazine has the melting point 155-157.



  The starting material can be obtained by condensing m-benzylmercapto-aniline of bp 163 at 0.06 mm Hg with the potassium salt of o-chlorobenzoic acid and the resulting N- (m-benzylmercapto-phenyl) -anthranilic acid (m.p. 137 to 139) decarboxylated by heating to 250. The N- (m-benzyl-mercapto-phenyl) -aniline formed is then distilled in a high vacuum. Bp 214 at 0.2 mm Hg, m.p. 61-63.



  <I> Example 9 </I> 3-Phenylmercapto-phenothiazine _ 10.0 g of N- (m-phenylmercapto-phenyl) aniline, 2.31 g of sulfur and 0.1 g of iodine powder are heated for 20 minutes in a bath of about 160. As soon as the evolution of hydrogen sulfide has practically ended, the reaction mixture is recrystallized first from 60 cm, then a second time from 50 cm of boiling benzene with the addition of animal charcoal. The pale yellow analytically pure 3-phenyhnercapto-phenothiazine has the constant melting point 163-165.



  The other isomer that may be formed during this reaction is in the mother liquor.



  The starting material can be obtained by condensing m-iodo-aniline (bp. 145-146 115 mm Hg) with the potassium salt of o-chlorobenzoic acid and the resulting N- (m-iodo-phenyl) -anthranilic acid (m.p. 168- 170) decarboxylated by heating and subsequent distillation to give N- (m-iodo-phenyl) -aniline (bp. 140 to 143 10.05 mm Hg). The N- (m-iodo-phenyl) -aniline obtained is converted to N- (m-phenylmercapto-phenyl) -aniline (boiling point 176 10.005 mm Hg) by condensation with sodium thiophenolate in the presence of copper powder.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von neuen, in 3-Stel- lung mit einer einwertigen Schwefelfunktion substi tuierten Phenothiazinen der Formel EMI0003.0039 R = H, Alkyl mit 1-4 C-Atomen, Alkenyl mit 2-4 C-Atomen, Aryl, Aralkyl oder Acyl dadurch gekennzeichnet, dass man Diphenylamin, dessen einer Phenylkern in m-Stellung den Substi- tuenten -S-R trägt, mit elementarem Schwefel oder mit Schwefeldihalogeniden behandelt. PATENT CLAIM Process for the production of new phenothiazines of the formula ## STR3 ## substituted in the 3-position with a monovalent sulfur function EMI0003.0039 R = H, alkyl with 1-4 carbon atoms, alkenyl with 2-4 carbon atoms, aryl, aralkyl or acyl, characterized in that diphenylamine, one of which has a phenyl nucleus in the m-position, bears the substituent -SR elemental sulfur or treated with sulfur dihalides. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch ge kennzeichnet, dass man die entstandenen Stellungs- isomeren voneinander trennt. 2. Verfahren nach Patentanspruch und Unter anspruch 1, dadurch gekennzeichnet, dass man N-(m-Äthylmercapto-phenyl)-anilin verwendet. SUBClaims 1. The method according to claim, characterized in that the positional isomers formed are separated from one another. 2. The method according to claim and sub-claim 1, characterized in that N- (m-ethylmercapto-phenyl) aniline is used.
CH3228356A 1956-04-18 1956-04-18 Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function CH365379A (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
CH3228356A CH365379A (en) 1956-04-18 1956-04-18 Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function
CH5646256A CH364794A (en) 1956-04-18 1956-04-18 Process for the preparation of new mercapto-diphenylamines
CH360059D CH360059A (en) 1956-04-18 1956-04-19 Process for the preparation of new phenothiazines substituted in the 3-position with a monovalent sulfur function
ES0234296A ES234296A1 (en) 1956-04-18 1957-03-18 Procedure for the obtaining of phenotyacinic derivatives, replaced in position 3 by a monovative sulfur function (Machine-translation by Google Translate, not legally binding)
DE1957S0052942 DE1128856B (en) 1956-04-18 1957-03-29 Process for the preparation of phenthiazine derivatives substituted in the 3-position by sulfur-containing groups
GB1105057A GB863547A (en) 1956-04-18 1957-04-04 3-mercapto-phenthiazine
GB1738060A GB863550A (en) 1956-04-18 1957-04-04 3-mercapto-phenthiazines
US653058A US3239514A (en) 1956-04-18 1957-04-16 Phenothiazine derivatives substituted by a monovalent sulfur function in 3-position
BE556725A BE556725A (en) 1956-04-18 1957-04-16
NL216435A NL105267C (en) 1956-04-18 1957-04-17
NL216436A NL105268C (en) 1956-04-18 1957-04-17
FR1174268D FR1174268A (en) 1956-04-18 1957-04-17 New phenothiazine derivatives and their preparation
BE565470A BE565470A (en) 1956-04-18 1958-03-06
FR1203557D FR1203557A (en) 1956-04-18 1958-03-07 New basic derivatives of 3 alkyl mercapto phenothiazine substituted on nitrogen and their preparation
DE1958S0057244 DE1090667B (en) 1956-04-18 1958-03-07 Process for the preparation of basic phenthiazine derivatives
CH5676458A CH374675A (en) 1956-04-18 1958-03-07 Process for the preparation of new sulfur-containing phenothiazine derivatives
NL225621A NL108580C (en) 1956-04-18 1958-03-07
GB748158A GB858140A (en) 1956-04-18 1958-03-07 The preparation of new basic phenothiazine derivatives
CY27564A CY275A (en) 1956-04-18 1964-02-12 The preparation of new basic phenothiazine derivatives
US420821A US3336197A (en) 1956-04-18 1964-12-23 Phenothiazine derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3228356A CH365379A (en) 1956-04-18 1956-04-18 Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function
CH4301757A CH364782A (en) 1957-02-22 1957-02-22 Process for the preparation of 3-sulfhydryl-10- (2 '- (N-methyl-piperidyl-2 ") - ethyl-1') - phenothiazine

Publications (1)

Publication Number Publication Date
CH365379A true CH365379A (en) 1962-11-15

Family

ID=25736343

Family Applications (2)

Application Number Title Priority Date Filing Date
CH3228356A CH365379A (en) 1956-04-18 1956-04-18 Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function
CH360059D CH360059A (en) 1956-04-18 1956-04-19 Process for the preparation of new phenothiazines substituted in the 3-position with a monovalent sulfur function

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH360059D CH360059A (en) 1956-04-18 1956-04-19 Process for the preparation of new phenothiazines substituted in the 3-position with a monovalent sulfur function

Country Status (7)

Country Link
BE (2) BE556725A (en)
CH (2) CH365379A (en)
CY (1) CY275A (en)
DE (2) DE1128856B (en)
FR (2) FR1174268A (en)
GB (3) GB863550A (en)
NL (3) NL105267C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL295220A (en) * 1962-07-19
CH457442A (en) * 1965-01-12 1968-06-15 Sandoz Ag Process for the preparation of new phenothiazine derivatives
IT1237209B (en) * 1989-12-21 1993-05-27 Zambon Spa PROCESS FOR DIRECT AND REGIO-SELECTIVE FUNCTIONALIZATION IN POSITION 2 OF PHENOTHIAZINE
US6800656B2 (en) 2000-01-07 2004-10-05 Warner Lambert Company Tricyclic compounds and method of treating herpes virus
DE102010062810B4 (en) * 2010-09-07 2014-03-13 Immungenetics Ag 2- (R2-thio) -10- [3- (4-R1-piperazin-1-yl) -propyl] -10H-phenothiazines for the treatment of neurodegenerative diseases selected from beta-amyloidopathies and alpha-synucleinopathies
WO2015135947A1 (en) * 2014-03-10 2015-09-17 Universite D'aix-Marseille Piperazine phenothiazine derivatives for treating spasticity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE910301C (en) * 1950-12-21 1954-04-29 Rhone Poulenc Sa Process for the production of new phenthiazine derivatives
CH298685A (en) * 1951-06-28 1954-05-15 Rhone Poulenc Chemicals Process for the preparation of a novel derivative of phenothiazine.
DE939630C (en) * 1953-10-25 1956-03-01 Basf Ag Process for the preparation of heterocyclic compounds with a ring-shaped imino group substituted by basic groups
BE558008A (en) * 1956-06-21

Also Published As

Publication number Publication date
DE1128856B (en) 1962-05-03
DE1090667B (en) 1960-10-13
FR1203557A (en) 1960-01-20
BE556725A (en) 1957-10-16
BE565470A (en) 1958-09-06
FR1174268A (en) 1959-03-09
NL105268C (en) 1963-07-15
GB863550A (en) 1961-03-22
CY275A (en) 1964-02-12
GB858140A (en) 1961-01-04
NL105267C (en) 1963-07-15
CH360059A (en) 1962-02-15
NL108580C (en) 1964-06-15
GB863547A (en) 1961-03-22

Similar Documents

Publication Publication Date Title
US2441069A (en) 2-amino-methyl-indenes and their production
US3719712A (en) 2-phenylethynyl-benzyl-amines
Cairns The Preparation and Attempted Resolution of 2, 2-Dimethylethyleneimine
JP2935137B2 (en) Arylcyclohexylamine-containing neuroprotective drug composition
DE2136571C2 (en) Phenyl-2-pyrrolidinones, process for their preparation and pharmaceuticals containing them
CH365379A (en) Process for the preparation of new phenothiazines substituted in the 3-position by a monovalent sulfur function
US2784226A (en) Nu-(cyclopropylmethyl)-cyclohexylamine
DE2514673A1 (en) BENZO (B) BICYCLO SQUARE BRACKET ON 3,3,1 SQUARE BRACKET FOR NONA-3,6 (10A) SERVING
US2681931A (en) Basic amides of bicyclo [2. 2.1]-5-heptene-2-carboxylic acid and 2-norcamphanecarboxylic acid and derivatives thereof
Makino et al. The Conversion of 5-Hydroxykynurenine to 6-Hydroxykynurenic Acid and 6, 4-Dihydroxyquinoline with Liver Homogenates
US2740795A (en) Isoindolineicompounds
JP2967231B2 (en) 1,4-thiazine derivatives
DE946058C (en) Process for the preparation of 3-aminoindanes
DE957573C (en) Process for the preparation of capsules of 10- (aminoalkyl) acridanes
AT205980B (en) Process for the preparation of new phenothiazine derivatives substituted in the 3-position by a monovalent sulfur function
BE576894A (en)
Snyder et al. Amine Replacement Reactions of α-Dimethylaminomethyl-β-methoxynaphthalene
DE942511C (en) Process for the preparation of basic compounds of the monobenzo- and dibenzopyran series
FI56825C (en) FRAMEWORK FOR THE FRAMEWORK OF ANALYTICAL BASIS
CH402843A (en) Process for the production of new naphthalene compounds
CH449647A (en) Compounds for the preparation of substituted hydrazine compounds
AT221515B (en) Process for the preparation of new 4-oxo-1,2,3,4-tetrahydronaphthalene-carboxamides
AT210427B (en) Process for the preparation of a new 10-pyrido [3, 2-b] [1, 4] benzthiazine derivative substituted with a monovalent sulfur function
Taguchi et al. Thermal, Solvolytic and Base-catalyzed Decomposition of 2-Acylaminoalkyl-S, S-dimethylsulfonium Iodides1
Coleman et al. THE PREPARATION OF VARIOUS OMEGA-CYCLOHEXYL ALKYL AMINES AND THEIR BACTERICIDAL ACTION TO MYCOBACTERIUM LEPRAE. XXII1